2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

Published on Aug 1, 2017in European Journal of Vascular and Endovascular Surgery3.642
· DOI :10.1016/j.ejvs.2017.07.018
Victor Aboyans52
Estimated H-index: 52
Jean-Baptiste Ricco28
Estimated H-index: 28
+ 49 AuthorsJ.L. Zamorano82
Estimated H-index: 82
Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate. A great number of guidelines have been issued in recent years by the European Society of Cardiology (ESC), by the European Society of Vascular Surgery (ESVS) and by the European Stroke Organization (ESO), as well as by other societies and organisations. Because of the impact on clinical practice, quality criteria for the development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines can be found on the ESC Website ( ESC Guidelines represent the official position of the ESC on a given topic and are regularly updated. Members of this Task Force were selected by the ESC, including representation from the ESVS and ESO to represent professionals involved with the medical care of patients with this pathology. Selected experts in the field undertook a comprehensive review of the published evidence for management of a given condition according to ESC Committee for Practice Guidelines (CPG) policy and approved by the ESVS and ESO. A critical evaluation of diagnostic and therapeutic procedures was performed, including assessment of the risk–benefit ratio. The level of evidence and the strength of the recommendation of particular management options were weighed and graded according to predefined scales, as outlined in Tables 1 and 2.
  • References (425)
  • Citations (176)
📖 Papers frequently viewed together
4,951 Citations
454 Citations
380 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Muriel Sprynger (University of Liège)H-Index: 8
#2Fausto RigoH-Index: 33
Last. Maurizio GalderisiH-Index: 58
view all 24 authors...
2 CitationsSource
#1Jean-Philippe Collet (University of Paris)H-Index: 34
#2Guillaume Cayla (University of Montpellier)H-Index: 32
Last. Gilles Montalescot (University of Paris)H-Index: 89
view all 15 authors...
Abstract Background The prevalence and associated-risk of asymptomatic multisite artery disease (MSAD) in high risk coronary patients are unknown. Whether systematic identification and aggressive management of asymptomatic MSAD is clinically relevant in high risk coronary patients has not been evaluated. Methods We randomly assigned 521 high risk coronary patients defined by the presence of three-vessel coronary disease (n = 304) or recent acute coronary syndrome beyond the age of 75 years (n = ...
6 CitationsSource
#1Risha Lane (Hull Royal Infirmary)H-Index: 2
#2Amy E. Harwood (Hull Royal Infirmary)H-Index: 3
Last. Gillian Leng (National Institute for Health and Care Excellence)H-Index: 9
view all 4 authors...
Background Exercise programmes are a relatively inexpensive, low-risk option compared with other more invasive therapies for leg pain on walking (intermittent claudication (IC)). This is an update of a review first published in 1998. Objectives The prime objective of this review was to determine whether an exercise programme in people with intermittent claudication was effective in alleviating symptoms and increasing walking treadmill distances and walking times. Secondary objectives were to det...
537 CitationsSource
BackgroundEvolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%. Whether it prevents cardiovascular events is uncertain. MethodsWe conducted a randomized, double-blind, placebo-controlled trial involving 27,564 patients with atherosclerotic cardiovascular disease and LDL cholesterol levels of 70 mg per deciliter (1.8 mmol per liter) or higher who were receiving stati...
1,234 CitationsSource
Dedication These guidelines are dedicated to Paola De Rango, University of Perugia, Italy. She participated very actively in the process of developing these guidelines, in particular the important chapters on chronic arterial and venous mesenteric ischaemia. Six days after the second meeting of the task force she died unexpectedly, to our great despair and loss. We honour her dedication and scientific integrity by completing these guidelines. Among many other commitments she was a very productiv...
50 CitationsSource
#1Victor Aboyans (French Institute of Health and Medical Research)H-Index: 52
#2Ileana Desormais (French Institute of Health and Medical Research)H-Index: 13
Last. Philippe Lacroix (French Institute of Health and Medical Research)H-Index: 24
view all 6 authors...
Objective/Background The objective was to determine the prevalence and clinical determinants of renal artery stenosis (RAS) in patients undergoing digital subtraction angiography (DSA) for the assessment of peripheral artery disease (PAD), and to evaluate its prognostic significance. Methods All DSAs performed from January 2000 to January 2006 were retrospectively reviewed for assessment of PAD in patients naive for any prior revascularisation of lower-limb arteries. All DSA studies were read by...
5 CitationsSource
#1K.I. Paraskevas (Leicester Royal Infirmary)H-Index: 1
#2S. Nduwayo (Leicester Royal Infirmary)H-Index: 1
Last. Naylor A. Ross (Leicester Royal Infirmary)H-Index: 54
view all 4 authors...
Objectives The aim was to determine 30-day outcomes in patients with concurrent carotid and cardiac disease who underwent carotid artery stenting (CAS) followed by coronary artery bypass grafting (CABG). Methods This was a systematic review with searches of PubMed/Medline, Embase, and Cochrane databases. "Same-day" procedures involved CAS + CABG being performed on the same day, and "staged" interventions involved at least 1 day's delay between undergoing CAS and then CABG. Results There were 31 ...
14 CitationsSource
#1Tristan MiraultH-Index: 14
#2A. GalloulaH-Index: 2
Last. Emmanuel MessasH-Index: 27
view all 9 authors...
5 CitationsSource
#1William R. Hiatt (Edin.: University of Edinburgh)H-Index: 74
#2F. Gerry R. Fowkes (Duke University)H-Index: 2
Last. Manesh R. Patel (Duke University)H-Index: 80
view all 14 authors...
BackgroundPeripheral artery disease is considered to be a manifestation of systemic atherosclerosis with associated adverse cardiovascular and limb events. Data from previous trials have suggested that patients receiving clopidogrel monotherapy had a lower risk of cardiovascular events than those receiving aspirin. We wanted to compare clopidogrel with ticagrelor, a potent antiplatelet agent, in patients with peripheral artery disease. MethodsIn this double-blind, event-driven trial, we randomly...
162 CitationsSource
9 CitationsSource
Cited By176
#1Athanasios Saratzis (NIHR: National Institute for Health Research)H-Index: 1
#2Talia Lea (St Thomas' Hospital)
Last. Hany Zayed (NIHR: National Institute for Health Research)H-Index: 1
view all 10 authors...
Objective Paclitaxel based drug coated balloons (DCBs) and drug eluting stents (DESs) may be associated with increased mortality in patients with peripheral arterial occlusive disease (PAOD), based on a recent meta-analysis. This study, however, had a number of limitations, which have been discussed at great length among the vascular community. The aim of this research was to assess the association between paclitaxel based endovascular treatment (PTX) in the femoropopliteal (F–P) segment and mor...
1 CitationsSource
#1David Hageman (UM: Maastricht University)H-Index: 3
#2Hugo J.P. Fokkenrood (Radboud University Nijmegen)
Last. Joep A.W. Teijink (UM: Maastricht University)H-Index: 33
view all 7 authors...
Abstract Objective The “gold standard” treatment of intermittent claudication (IC) is supervised exercise therapy (SET). Intermittent vacuum therapy (IVT) has recently been promoted as an additional treatment of IC. During IVT, negative pressure and atmospheric pressure are alternatingly applied to the lower extremities, possibly resulting in improved circulation. The aim of this study was to determine a potential additional effect of IVT in IC patients undergoing a standardized SET program. Met...
#1Raffaello BellostaH-Index: 8
#2Luca LuzzaniH-Index: 9
Last. Ruth L. Bush (UH: University of Houston)H-Index: 19
view all 11 authors...
Objectives The aim of our study is to describe the incidence and characteristics, as well as clinical outcomes of patients presenting and treated for acute limb ischemia (ALI) in patients with novel coronavirus (COVID-19) infection during the 2020 coronavirus pandemic. Methods This is a single center, observational cohort study. Data of all patients tested positive with COVID-19 and presented with ALI vascular diseases requiring urgent operative treatment were collected in a prospectively mainta...
#1Jonathan Golledge (JCU: James Cook University)H-Index: 48
#2Anthony S. Leicht (JCU: James Cook University)H-Index: 22
Last. Yorgi Mavros (RMIT: RMIT University)H-Index: 8
view all 15 authors...
Objective The aims of this study were firstly to assess the correlation between disease specific measures of quality of life (QOL) and physical performance and activity, and secondly to identify demographic, clinical, functional, and physical activity measures independently associated with QOL in people with intermittent claudication. Methods This was a cross sectional observational study of 198 people with intermittent claudication caused by peripheral artery disease who were recruited prospect...
#1Ronald Lg Flumignan (UNIFESP: Federal University of São Paulo)H-Index: 1
#2Virgı́nia M.F Trevisani (UNIFESP: Federal University of São Paulo)H-Index: 2
Last. Luis Cu Nakano (UNIFESP: Federal University of São Paulo)H-Index: 1
view all 6 authors...
#1Corey A. Kalbaugh (Clemson University)H-Index: 20
#2Paula D. Strassle (UNC: University of North Carolina at Chapel Hill)H-Index: 8
Last. William A. Marston (UNC: University of North Carolina at Chapel Hill)H-Index: 37
view all 6 authors...
Background Major lower limb amputation is an important cause of morbidity and mortality in the USA. Little is known about the prevalence of the various indications for amputation, or if these indications have changed over time. The purpose of this study was to assess the indications for major amputation over a 17 year period and to determine whether surgical indications have shifted over this time period. Methods A retrospective, population based analysis of patients undergoing major amputation ...
#1Charlotte Harth (Ghent University Hospital)H-Index: 1
#2Caren Randon (Ghent University Hospital)H-Index: 10
Last. Frank Vermassen (Ghent University Hospital)H-Index: 35
view all 3 authors...
Background In the presence of long lesions, in patients with chronic limb threatening ischaemia, a femorodistal bypass is often the only option to avoid major amputation. This study investigated whether targeted bypass to the affected angiosome, according to the angiosome concept definition of direct (DR) and indirect revascularisation (IR), has an impact on wound healing, major amputation rate, and mortality. Methods A retrospective analysis was performed at Ghent University Hospital of 201 non...
1 CitationsSource
#1Mahim I Qureshi (UoB: University of Bristol)H-Index: 5
#2Hang L. Li (UoB: University of Bristol)
Last. Christopher P. Twine (UoB: University of Bristol)H-Index: 7
view all 9 authors...
Objective Randomised trials of new devices for peripheral arterial endovascular intervention are published regularly. The evidence for which antiplatelet and/or anticoagulant (antithrombotic) therapy to use after an intervention is lacking. The aim of this systematic review was to examine the antithrombotic regimens in randomised trials for peripheral arterial endovascular intervention to understand choices made and trends with time or type of device. Methods Data sources were the Medline, Embas...